Legal Opinion
ALBERICI v. RECRO PHARMA, INC.
District Court, E.D. Pennsylvania
Decided March 1, 2021No. 2:18-cv-02279Unknown
1Opinion
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA JOHN ALBERICI, individually and on CIVIL ACTION behalf of all others similarly situated NO. 18-2279 v. RECRO PHARMA, INC., GERALDINE A. HENWOOD, STEWART MCCALLUM, and JOHN HARLOW MEMORANDUM RE SECOND MOTION TO DISMISS AMENDED COMPLAINT Baylson, J. March 1, 2021 I. Introduction In the present case, Plaintiff alleges that Recro Pharma Inc. concealed concerns about a drug’s efficacy and manufacturing quality control. As alleged, Recro’s investors learned of these issues only after the FDA refused to approve the drug —…
2Cases cited11 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- In Re Burlington Coat Factory Securities Litigation. P. Gregory Buchanan, Jacob Turner and Ronald AbramoffCourt of Appeals for the Third Circuit · 1997
- Warren General Hospital v. Amgen Inc.Court of Appeals for the Third Circuit · 2011
6 more not listed; retrieve them via the Exa API.